Evidence map›Paper›PMID 32992605›Full record

ArticleMolecules (Basel, Switzerland)2020

Isoliquiritigenin Pretreatment Induces Endoplasmic Reticulum Stress-Mediated Hormesis and Attenuates Cisplatin-Induced Oxidative Stress and Damage in LLC-PK1 Cells.

Tania Gómez-Sierra, Omar Noel Medina-Campos, José D Solano, María Elena Ibarra-Rubio, José Pedraza-Chaverri

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Recent Advances inMetabolites · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tania Gómez-SierraDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, CDMX 04510, Mexico.
Omar Noel Medina-CamposDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, CDMX 04510, Mexico.
José D SolanoDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, CDMX 04510, Mexico.
María Elena Ibarra-RubioDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, CDMX 04510, Mexico.
José Pedraza-ChaverriDepartamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, CDMX 04510, Mexico.ORCID 0000-0001-6628-4411
Universidad Nacional Autónoma de México · MX

Funding

Consejo Nacional de Ciencia y Tecnología A1-S-7495Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN202219Programa de Apoyo a la Investigación y al Posgrado PAIP 5000-9105
6 · The paper itself

Abstract

Isoliquiritigenin (IsoLQ) is a flavonoid with antioxidant properties and inducer of endoplasmic reticulum (ER) stress. In vitro and in vivo studies show that ER stress-mediated hormesis is cytoprotective; therefore, natural antioxidants and ER stress inducers have been used to prevent renal injury. Oxidative stress and ER stress are some of the mechanisms of damage involved in cisplatin (CP)-induced nephrotoxicity. This study aims to explore whether IsoLQ pretreatment induces ER stress and produces hormesis to protect against CP-induced nephrotoxicity in Lilly Laboratories Cell-Porcine Kidney 1 (LLC-PK1) cells. During the first stage of this study, both IsoLQ protective concentration and pretreatment time against CP-induced toxicity were determined by cell viability. At the second stage, the effect of IsoLQ pretreatment on cell viability, ER stress, and oxidative stress were evaluated. IsoLQ pretreatment in CP-treated cells induces expression of glucose-related proteins 78 and 94 kDa (GRP78 and GRP94, respectively), attenuates CP-induced cell death, decreases reactive oxygen species (ROS) production, and prevents the decrease in glutathione/glutathione disulfide (GSH/GSSG) ratio, free thiols levels, and glutathione reductase (GR) activity. These data suggest that IsoLQ pretreatment has a moderately protective effect on CP-induced toxicity in LLC-PK1 cells, through ER stress-mediated hormesis, as well as by the antioxidant properties of IsoLQ.

Indexed as

AnimalsChalconesCisplatinEndoplasmic Reticulum StressHormesisLLC-PK1 CellsOxidative StressSwineChalconesCisplatinisoliquiritigenincisplatinER stresshormesisisoliquiritigeninnephrotoxicityoxidative stress

Identifiers

PMID32992605
PMCPMC7582730
OpenAlexW3089143697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.